Management of Uterine Arteriovenous Malformation: Uterine Artery Embolization followed by Gonadotropin-Releasing Hormone Agonist

被引：1
|
作者：
Li, He [1 ]
Yi, Xiaofang [2 ,3 ]
机构：
[1] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai, Peoples R China
[2] Fudan Univ, Dept Gynecol Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
来源：
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY | 2021年 / 28卷 / 05期
关键词：
LAPAROSCOPIC BIPOLAR COAGULATION;
D O I：
10.1016/j.jmig.2020.12.033
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：936 / 937
页数：2
相关论文
共 50 条
  • [21] Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists
    Weeks, AD
    Duffy, SRG
    Walker, JJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (01) : 8 - 13
  • [22] Gonadotropin-releasing hormone antagonists in the treatment of uterine leiomyoma
    Felberbaum, Ricardo E.
    Kuepker, Wolfgang
    Balogh, Balint
    Diedrich, Klaus
    GYNAKOLOGE, 2020, 53 (08): : 529 - 536
  • [23] Gonadotropin-releasing hormone agonist treatment on uterine leiomyomas increases the number of mast cells
    Nakayama, M
    Mitsuhashi, T
    Ban, S
    Shimizu, Y
    Ogawa, F
    Ishihara, O
    Shimizu, M
    MODERN PATHOLOGY, 2006, 19 : 190A - 190A
  • [24] TREATMENT WITH THE GONADOTROPIN-RELEASING HORMONE-AGONIST GOSERELIN BEFORE HYSTERECTOMY FOR UTERINE FIBROIDS
    LUMSDEN, MA
    WEST, CP
    THOMAS, E
    COUTTS, J
    HILLIER, H
    THOMAS, N
    BAIRD, DT
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (05): : 438 - 442
  • [25] USE OF A GONADOTROPIN-RELEASING HORMONE AGONIST TO MANAGE PERIMENOPAUSAL WOMEN WITH SYMPTOMATIC UTERINE MYOMAS
    Wang, Peng-Hui
    Lee, Wen-Ling
    Cheng, Ming-Huei
    Yen, Ming-Shyen
    Chao, Kuan-Chong
    Chao, Hsiang-Tai
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2009, 48 (02): : 133 - 137
  • [26] Gonadotropin-releasing hormone agonist treatment on uterine leiomyomas increases the number of mast cells
    Nakayama, M
    Mitsuhashi, T
    Ban, S
    Shimizu, Y
    Ogawa, F
    Ishihara, O
    Shimizu, M
    LABORATORY INVESTIGATION, 2006, 86 : 190A - 190A
  • [27] Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist
    Yu, KJ
    Lai, CR
    Sheu, MH
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 96 (02): : 223 - 225
  • [28] Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest
    Matsushima, Takashi
    Akira, Shigeo
    Yoneyama, Koichi
    Takeshita, Toshiyuki
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (06) : 521 - 524
  • [29] Comparing the Use of Uterine Artery Embolization to Gonadotropin-Releasing Hormone Agonists in Shrinking Fibroid Size: A Pilot Study in Kazakhstan
    Imankulova, Balkenzhe
    Mereke, Alibek
    Kamzaeva, Nazira
    Ukybassova, Talshyn
    CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH, 2015, 4 (01):
  • [30] Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas
    Neblett II, Michael F.
    Stewart, Elizabeth A.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05): : 901 - 910
12345